Due to current legislation regarding weight loss drugs, Medicare Part D or Part C plans with drug coverage may only cover Zepbound for treating obstructive sleep apnea (OSA). However, the Centers ...

Be sure to ask your insurance company whether Zepbound requires prior authorization. Currently, Medicare does not provide coverage for Zepbound for weight loss or weight management uses.

The Centers for Medicare & Medicaid Services on Friday rejected a Biden administration proposal to expand Medicare coverage of weight-loss drugs such as Eli Lilly's Zepbound and Novo Nordisk's ...

The CMS has opted not to move forward with a plan that would have extended Medicare coverage to obesity drugs for millions of Americans.

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

Medicare coverage for anti-obesity drugs was not finalized, affecting drugs like Wegovy and Zepbound. Covering weight loss drugs may cost $35 billion from 2026–2034, with estimated savings under ...

Medicare covers health care expenses mainly for people age 65 and older. Trump’s predecessor, Joe Biden, proposed a rule in late November after Trump won re-election that would have extended coverage ...

Medicare covers health care expenses mainly for people age 65 and older. President Joe Biden, proposed a rule in November that would have extended coverage of drugs like Zepbound and Wegovy.

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

Due to current legislation, Medicare Part D or C plans may only cover Zepbound for obstructive sleep apnea. However, the Centers for Medicare & Medicaid Services may expand weight loss medication ...

Advertisement Advertisement The Biden proposal would have included coverage of Wegovy and Zepbound to treat obesity under Medicare Part D for Medicare Advantage. “While today’s announcement ...